Cancer preventive potential of trichothecenes from Trichothecium roseum

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 12, 2003, Pages 2511-2518

  Konishi, Kazuhide ^a   Iida, Akira ^a   Kaneko, Masafumi ^a   Tomioka, Kiyoshi ^a   Tokuda, Harukuni ^b   Nishino, Hoyoku ^b   Kumeda, Yuko ^c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; TRICHODERMOL; TRICHOTHECENE; TRICHOTHECENE DERIVATIVE; TRICHOTHECINOL A; TRICHOTHECINOL B; TRICHOTHECINOL C; TRICHOTHECOLONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; CANCER PREVENTION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYPTOCOCCUS; EPSTEIN BARR VIRUS; FUNGICIDAL ACTIVITY; FUNGUS; INFRARED SPECTROMETRY; INHIBITION KINETICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SACCHAROMYCES CEREVISIAE; SKIN CANCER; SKIN CARCINOGENESIS; TRICHOTHECIUM ROSEUM; TUMOR PROMOTION;

FUNGI; HUMAN HERPESVIRUS 4; SACCHAROMYCES CEREVISIAE; TRICHOTHECIUM ROSEUM;

EID: 0037997111     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00215-3     Document Type: Article

References (49)

1. (a) Mcdougal P.G., Schmuff N.R. Prog. Chem. Org. Nat. Prod. 47:1985;153
2. (b) Grove J.F. Nat. Prod. Rep. 5:1988;187.
3. (a) Hsu I.C., Smalley E.B., Strong F.M., Ribelin W.E. Appl. Microbiol. 24:1972;684
4. (b) Smalley E.B.J. AM. Vet. Med. Assoc. 163:1973;1278;
5. (c) Mirocha C.J., Schauerhamer S.V., Christensen C.M. Appl. Environ. Microbiol. 32:1976;553;
6. (d) Ueno Y., Kawamura O. Jpn. J. Toxicol. Environ. Health. 39:1993;173.
7. (a) Schoental R., Joffe A.Z., Yagen B. Cancer Res. 39:1979;2179
8. (b) Buening G.M., Mann D.D., Hook B., Osweiler G.D. Vet. Immunol. Immunopathol. 3:1982;411;
9. (c) Ueno Y. Pure Appl. Chem. 49:1977;1737.
10. (a) Schoental R., Joffe A.Z. J. Pathol. 112:1974;37;
11. (b) Schoental R., Joffe A.Z., Yagen B.J. Cancer. 34:1976;310;
12. (c) Ueno Y. Dev. Food Sci. 4:1983;135.
13. Bamburg J.R. Proc. Mol. Subcell. Biol. 8:1983;41.
14. (a) Harri B., Loeffler W., Sigg H.P., Stahelin H., Stoll C., Tamm C., Wiesinger D. Helv. Chim. Acta. 45:1962;839;
15. (b) Doyle, T. W.; Bradner, W. T. In Anticancer Agent Based on Natural Product Model; Cassidy, J. M.; Douros, J. D., Eds.; Academic: New York, 1980; p 43.
16. (c) Jarvis B.B., Stahly G.P., Pavanasasivam G., Mazzola E. J. Med. Chem. 23:1980;1054;
17. (d) Kaneko T., Schmitz H., Essery J.M., Rose W., Howell H.G., O'Herron F.A., Nachfolger S., Huftalen J., Bradner W.T., Partyka R.A., Doyle T.W., Davies J., Cundliffe E. J. Med. Chem. 25:1982;579
18. (e) Anderson D.W., Black R.M., Lee C.G., Pottage C., Rickard R.L., Sandford M.S., Webber T.D., Williams N.E. J. Med. Chem. 32:1989;555.
19. (a) Ueno Y., Hosoya M., Ishikawa Y. J. Biochem. 66:1969;419;
20. (b) Cundliffe E., Cannon M., Davies J. Proc. Nat. Acad. Sci. U.S.A. 71:1974;30;
21. (c) Carter C.J., Cannon M. Eur. J. Biochem. 84:1978;103;
22. (d) Ehrlich K.C., Daigle K.W. Appl. Environ. Microbiol. 50:1985;914
23. (e) Ehrlich K.C., Daigle K.W. Biochim. Biophys. Acta. 923:1987;206.
24. (a) Wada S., Iida A., Tanaka R. J. Nat. Prod. 65:2000;1657
25. (b) Iida A., Mihara T., Fujita T., Takaishi Y. Bioorg. Med. Chem. Lett. 9:1999;3393.
26. Iida A., Konishi K., Kubo H., Tomioka K., Tokuda H., Nishino H. Tetrahedron Lett. 37:1996;9219.
27. (a) Freeman G.G., Gill J.J., Waring W.S. J. Chem. Soc. 1959:1959;1105;
28. (b) Godteredsen W.O., Vangedal S. Acta Chem. Scand. 19:1965;1088.
29. (a) Gutzwiller J., Mauli R., Sigg H.P., Tamm C. Helv. Chim. Acta. 47:1964;2234;
30. (b) Gutzwiller J., Tamm C., Sigg H.P. Tetrahedron Lett. 6:1965;4495;
31. (c) Gyimesi J., Melera A. Tetrahedron Lett. 8:1967;1665
32. (d) Hanson J.R., Marten T., Siverns M. J. Chem. Soc., Perkin Trans. 1. 1974;1033
33. (e) Evans R., Hanson J.R., Marten T. J. Chem. Soc. Perkin Trans. I. 1976;1212.
34. (a) Ito Y., Yanase S., Fujita J., Harayama T., Takashima M., Imanaka H. Cancer Lett. 13:1981;29
35. (b) Tokuda H., Ohigashi H., Koshimizu K., Ito Y. Cancer Lett. 33:1986;279.
36. Berenblum I. Cancer Res. 1:1941;44.
37. (a) Murakami A., Ohigashi H., Koshimizu K. Biosci. Biotech. Biochem. 60:1996;1
38. (b) Sporn M.B., Suh N. Carcinogenesis. 21:2000;525;
39. (c) Hong W.K., Spitz M.R., Lippman S.M. J. Clin. Oncol. 18:2000;9. s
40. (d) Croce C.M. Proc. Nat. Acad. Sci. U.S.A. 98:2001;10986.
41. Ohtani I., Kusumi T., Kashman Y., Kawashima H. J. Am. Chem. Soc. 113:1991;4092.
42. Ishida J., Kozuka M., Wang H.K., Konoshima T., Tokuda H., Okuda M., Mou X.Y., Nishio H., Sakurai N., Lee K.H., Nagai M. Cancer Lett. 159:2000;135.
43. Busam L., Habermehl G.G. Naturwissenschaften. 69:1982;392.
44. Iida A., Konishi K., Matsumoto H., Kaneko M., Tomioka K. Heterocycles. 59:2003;595.
45. (a) Yamamoto I., Henmi T., Yamano T. Ann. Rep. Takeda Res. Lab. (Takeda Kenkyusho Nempo). 28:1969;69;
46. (b) Corley D.G., Miller-Wildman M., Durley R.C. J. Nat. Prod. 57:1994;422.
47. Henle G., Henle W. J. Bacteriol. 91:1966;1248.
48. Ohigashi H., Takamura H., Koshimizu K., Tokuda H., Ito Y. Cancer Lett. 30:1986;143.
49. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (Proposal Standard M27-P); NCCLS: Villanova, PA, 1992.